These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 32586581)

  • 1. Treatment of Histologic Transformation.
    Casulo C
    Hematol Oncol Clin North Am; 2020 Aug; 34(4):785-794. PubMed ID: 32586581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transformed follicular lymphoma.
    Fischer T; Zing NPC; Chiattone CS; Federico M; Luminari S
    Ann Hematol; 2018 Jan; 97(1):17-29. PubMed ID: 29043381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transformation in follicular lymphoma: biology, prognosis, and therapeutic options.
    Wong E; Dickinson M
    Curr Oncol Rep; 2012 Oct; 14(5):424-32. PubMed ID: 22865028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis and management of follicular lymphoma: A comprehensive review.
    Dada R
    Eur J Haematol; 2019 Sep; 103(3):152-163. PubMed ID: 31270855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and Biological Prognostic Factors in Follicular Lymphoma.
    Patel AA; Smith SM
    Hematol Oncol Clin North Am; 2020 Aug; 34(4):647-662. PubMed ID: 32586571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transformed follicular non-Hodgkin lymphoma.
    Casulo C; Burack WR; Friedberg JW
    Blood; 2015 Jan; 125(1):40-7. PubMed ID: 25499449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transformation of follicular lymphoma.
    Lossos IS; Gascoyne RD
    Best Pract Res Clin Haematol; 2011 Jun; 24(2):147-63. PubMed ID: 21658615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transformed lymphoma: an Achilles' heel of non-Hodgkin's lymphoma.
    Lerner RE; Burns LJ
    Bone Marrow Transplant; 2003 Apr; 31(7):531-7. PubMed ID: 12692617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of patients with transformed lymphoma.
    Montoto S
    Hematology Am Soc Hematol Educ Program; 2015; 2015():625-30. PubMed ID: 26637780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The incidence of biopsy-proven transformation in follicular lymphoma in the rituximab era. A retrospective analysis from the Czech Lymphoma Study Group (CLSG) database.
    Janikova A; Bortlicek Z; Campr V; Kopalova N; Benesova K; Hamouzova M; Belada D; Prochazka V; Pytlik R; Vokurka S; Pirnos J; Duras J; Mocikova H; Mayer J; Trneny M
    Ann Hematol; 2018 Apr; 97(4):669-678. PubMed ID: 29318369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transformed lymphoma: what should I do now?
    Smith S
    Hematology Am Soc Hematol Educ Program; 2020 Dec; 2020(1):306-311. PubMed ID: 33275671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of transformed follicular lymphoma in the modern era: a report from the National LymphoCare Study (NLCS).
    Wagner-Johnston ND; Link BK; Byrtek M; Dawson KL; Hainsworth J; Flowers CR; Friedberg JW; Bartlett NL
    Blood; 2015 Aug; 126(7):851-7. PubMed ID: 26105149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population-based analysis of incidence and outcome of transformed non-Hodgkin's lymphoma.
    Al-Tourah AJ; Gill KK; Chhanabhai M; Hoskins PJ; Klasa RJ; Savage KJ; Sehn LH; Shenkier TN; Gascoyne RD; Connors JM
    J Clin Oncol; 2008 Nov; 26(32):5165-9. PubMed ID: 18838711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Follicular lymphoma grade 3: review and updates.
    Vaidyanathan G; Czuczman MS
    Clin Lymphoma Myeloma Leuk; 2014 Dec; 14(6):431-5. PubMed ID: 25066038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel acquisitions on biology and management of transformed follicular lymphoma.
    Minoia C; Zucca E; Conconi A
    Hematol Oncol; 2018 Oct; 36(4):617-623. PubMed ID: 29602222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The tumour microenvironment influences survival and time to transformation in follicular lymphoma in the rituximab era.
    Blaker YN; Spetalen S; Brodtkorb M; Lingjaerde OC; Beiske K; Østenstad B; Sander B; Wahlin BE; Melen CM; Myklebust JH; Holte H; Delabie J; Smeland EB
    Br J Haematol; 2016 Oct; 175(1):102-14. PubMed ID: 27341313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unraveling transformation of follicular lymphoma to diffuse large B-cell lymphoma.
    González-Rincón J; Méndez M; Gómez S; García JF; Martín P; Bellas C; Pedrosa L; Rodríguez-Pinilla SM; Camacho FI; Quero C; Pérez-Callejo D; Rueda A; Llanos M; Gómez-Codina J; Piris MA; Montes-Moreno S; Bárcena C; Rodríguez-Abreu D; Menárguez J; de la Cruz-Merino L; Monsalvo S; Parejo C; Royuela A; Kwee I; Cascione L; Arribas A; Bertoni F; Mollejo M; Provencio M; Sánchez-Beato M
    PLoS One; 2019; 14(2):e0212813. PubMed ID: 30802265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting transformation in follicular lymphoma.
    de Jong D; de Boer JP
    Leuk Lymphoma; 2009 Sep; 50(9):1406-11. PubMed ID: 19606378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histologic transformation in follicular lymphoma.
    Salles G; Coiffier B
    Ann Oncol; 1998 Aug; 9(8):803-5. PubMed ID: 9789600
    [No Abstract]   [Full Text] [Related]  

  • 20. Primary refractory follicular lymphoma: a poor outcome entity with high risk of transformation to aggressive B cell lymphoma.
    Alonso-Álvarez S; Manni M; Montoto S; Sarkozy C; Morschhauser F; Wondergem MJ; Guarini A; Magnano L; Alcoceba M; Chamuleau M; Galimberti S; Gomes da Silva M; Holte H; Zucca E; Lockmer S; Aurer I; Marcheselli L; Stepanishyna Y; Caballero Barrigón MD; Salles G; Federico M
    Eur J Cancer; 2021 Nov; 157():132-139. PubMed ID: 34508995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.